Post-RP prognosis was distinguishable at a nadir PSA level of ≤0.03 ng/mL vs higher. A PSA level of 0.04 ng/mL or higher may optimally define PSA persistence in patients who have had radical ...

Prostate cancer is the most common form of cancer among men in England, with cases surging by 25 per cent between 2019 and 2023, according to NHS data. It’s also the second-deadliest form of the ...

In honor of Prostate Cancer Awareness Month in September, Cleveland Diagnostics has proudly relaunched its PSA on PSA ...

Prostate cancer is one of the most prevalent cancers in males, which can grow silently at the initial phase. Increased ...

The PSA test is often paired with a digital rectal exam (DRE), where a doctor inserts their finger into the rectum to feel ...

Discover a study showing how repeating elevated PSA tests can prevent unnecessary procedures, while persistent elevations ...

Cleveland Diagnostics, whose first offering is a test for prostate cancer, will donate $3 to the nonprofit Zero Prostate Cancer just because this reporter downloaded ‘A PSA on PSA’ fact sheet from ...

A significant proportion of men with elevated prostate-specific antigen levels see their values drop below biopsy thresholds ...

Please provide your email address to receive an email when new articles are posted on . At any given PSA level, Black men are more likely than white men to harbor prostate cancer, according to ...

CLEVELAND--(BUSINESS WIRE)--Cleveland Diagnostics, Inc., a leading commercial-stage biotechnology company, is launching its inaugural Prostate Cancer Awareness Campaign this September: ‘A PSA on PSA.’ ...

CLEVELAND--(BUSINESS WIRE)--This September, cancer biotech company Cleveland Diagnostics, Inc. launches ‘A PSA on PSA.’ Short for ‘A Public Service Announcement on the Prostate-Specific Antigen,’ the ...

Jesse Bennett, a two-time prostate cancer survivor and Morgan State University health education graduate, uses his journey to inspire other men to take charge of their health by learning their PSA ...